Norimode (Loperamide Hydrochloride)

Loperamide Hydrochloride, the active ingredient in Norimode, is a peripheral μ‑opioid receptor agonist presented as an oral dosage form for oral use in adult patients. It reduces intestinal motility and is employed to manage acute and chronic diarrhea, including irritable bowel syndrome with diarrhea.

GNH USA supplies Norimode as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable global distribution.

Norimode, a peripheral μ‑opioid receptor agonist, is indicated for conditions affecting intestinal fluid balance and motility.

- Acute nonspecific diarrhea: reduces stool frequency and liquidity, helping restore normal bowel movements. - Chronic diarrhea: provides symptomatic relief by slowing intestinal transit. - Irritable bowel syndrome with diarrhea (IBS‑D): alleviates diarrhea‑predominant symptoms and improves quality of life.

Loperamide may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Abdominal cramps - Constipation - Nausea - Dry mouth - Dizziness

Serious or Rare Side Effects: - Severe constipation or intestinal obstruction - Toxic megacolon - Allergic reactions such as rash, urticaria, or angioedema - Cardiac arrhythmias (e.g., QT prolongation)

When using Norimode, several precautions should be observed to ensure safe and effective therapy.

- Assess dehydration: evaluate fluid and electrolyte status before initiating therapy. - Hepatic impairment: use with caution in patients with liver disease, adjusting duration as needed. - Pediatric use: avoid in children under two years of age unless specifically directed by a physician. - Dose limits: do not exceed the recommended maximum daily dose to reduce risk of constipation. - Monitor for constipation: discontinue if severe constipation or signs of obstruction develop. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Loperamide can interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Concomitant antidiarrheal agents: combined use may cause excessive slowing of gut motility. - Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): increase plasma loperamide levels, raising risk of cardiac toxicity. - Opioid analgesics: additive opioid effects may enhance central nervous system depression.

Moderate Interactions (Monitor Closely): - Anticholinergic drugs: may potentiate constipation. - Antihistamines: can increase risk of drowsiness and dry mouth. - Certain antibiotics (e.g., clarithromycin): may modestly raise loperamide concentrations.